KM
Kyriaki Michailidou
Cyprus Institute of Neurology and Genetics, University of Cambridge, University of Oxford, Aristotle University of Thessaloniki
Research areas: Biochemistry, Genetics and Molecular Biology · Genetics · Genetic Associations and Epidemiology · BRCA gene mutations in cancer · Cancer Risks and Factors
Employment
-
The Cyprus Institute of Neurology and Genetics Senior Scientist2026 - Present
- 2023 - 2025
-
The Cyprus Institute of Neurology and Genetics Associate Scientist2019 - 2023
-
Cyprus Institute of Neurology and Genetics Post-doctoral Fellow2015 - 2019
-
University of Cambridge Research Associate/Statistician2009 - 2015
Education
- 2011 - 2015
- 2008 - 2009
- 2004 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (216)
- Fine-mapping of breast cancer susceptibility loci highlights critical methodological dependencies and the value of complementary approaches Save
- ClinGen Hemoglobinopathy VCEP ACMG/AMP specifications for HBB and HBA2 variant interpretation in thalassemia Save
- The Effects of In-Phase Bilateral Upper-Limb Exercises on Corticospinal Plasticity in People with Progressive Multiple Sclerosis: A Pilot Randomized Single-Case Concurrent Multiple-Baseline Design Save
- Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer Save
- Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis Save
- Interactions between genetic and epidemiological factors influencing mammographic density Save
- Comparative fine-mapping of breast cancer susceptibility loci using summary statistics methods and multinomial regression Save
- Mitoepigenetic Alterations in Early-Onset Parkinson’s Disease Save
- In-Phase Bilateral Upper Limb Exercises Improve Cognitive and Motor Functions in Progressive Multiple Sclerosis: A Pilot Randomized Controlled Trial Save
- Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study Save
- In-phase bilateral upper limb exercises improve cognitive and motor function in Progressive Multiple Sclerosis: A pilot randomized controlled trial Save
- Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women Save
- Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk Save
- Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer Save
- Saturation genome editing-based clinical classification of BRCA2 variants Save
- The FGF14 GAA repeat expansion is a major cause of ataxia in the Cypriot population Save
- Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG AMP guidelines Save
- Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel Save
- Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases Save
- Data from A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women Save